
Afayro 30mg Tablet
Salt Composition: Afatinib
Expiry Date: 01/2028
Inclusive of all taxes
28
About The Product
Lung Cancer, monotherapy
Description
Afayro 30mg tablet is an ant-cancer medication which is a prescription based medication used to treat non small cell lung cancer (NSCLC). It works by blocking the epidermal growth factor (EGFR) which is involved for the growth and multiplication of cancer cells, thereby helping to slow or stop tumor growth.
The active ingredient in the medication is Afatinib, which is a salt form used in the tablet.The medication is used alone as it is a monotherapy medication. Patient should take it exactly as prescribed by the doctor, all medical instructions carefully and report any side effects or unusual symptoms promptly.
Indication
Non small cell lung cancer (NSCLC)
Common side effects
- Like other medication Afayro 30mg tablet cause various side effects, some may resolve on their own and some need proper medication to relieve the symptoms.
- Consult the doctor If the symptoms worsen: ● Diarrhea ● Mouth sores ● Acne or skin rash ● Nausea and vomiting ● Fatigue ● Loss of appetite ● Abdominal pain ● Interstitial lung disease (ILD) ● Severe diarrhea or dehydration ● Liver problems ● Eye problems, such as corneal erosion or ulceration
Dosage and administration
- Doctor recommend the correct dosage and duration of Afayro 30mg tablet based on the patient's medical condition and response to the treatment.
- This tablet should be taken with a whole glass of water, do not crush or chew it take it as it is.
- Never skip or double the dose without consulting the doctor to ensure safety and effectiveness of the treatment.
Mechanism of action
Afayro 30g tablet is a targeted therapy which specifically target on the cancer cells that is most commonly those with mutation in the EGFR (epidermal growth factor receptor). The medication block EGFR mutation gene which is the responsible for the growth of cancer cells in the body.
It helps prevent the growth and multiplication of tumor cells in the body.
Safety advice
FAQs
Afayro 30mg tablet show various side effects such as diarrhea, mouth sores, fatigue, abdominal pain etc.
but they are manageable with proper care and regular medical guidance.
Reference
• Wecker, H., & Waller, C. F.
(2018). Afatinib.
Small Molecules in Oncology, 199-215. • Dungo, R. T., & Keating, G.
M. (2013).
Afatinib: first global approval. Drugs, 73(13), 1503-1515. • Wind, S., Schnell, D., Ebner, T., Freiwald, M., & Stopfer, P.
(2017). Clinical pharmacokinetics and pharmacodynamics of afatinib.
Clinical pharmacokinetics, 56(3), 235-250. • Nelson, V., Ziehr, J., Agulnik, M., & Johnson, M. (2013).
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC. OncoTargets and therapy, 135-143. • Keating, G.
M. (2014).
Afatinib: a review of its use in the treatment of advanced non-small cell lung cancer. Drugs, 74(2), 207-221.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
